Breaking News

Financial Report: Quintiles

May 1, 2014

Product Development revenues up 9% in the quarter


1Q Revenues: $1.3 billion (+6%)

1Q Earnings: $90.2 million  (+87%)

Comments: Product Development revenues grew 9% to $770.8 million, with growth in core clinical services in North America, clinical trial support services, and increases in global labs, and the Novella acquisition in 2013. Integrated Healthcare Service revenues were up 8% to $234.5 million, primarily due to increases in Japan and North America, as well as growth in real-world and late phase research services. Net new business wins were $1.27 billion in the quarter, representing a book-to-bill ratio of 1.27, contributing to an ending backlog of $10.1 billion at March 31st.
blog comments powered by Disqus
  • The Role of Value in Drug Pricing

    The Role of Value in Drug Pricing

    Keren Shani, Ryan Million, Trinity Partners ||October 11, 2016
    Exploring the trend of using frameworks and models to evaluate the value of a drug

  • CRO-Sponsor Partnerships

    CRO-Sponsor Partnerships

    Craig Morgan, Brand Development Director, goBalto Inc.||October 11, 2016
    10 tips for enabling better CRO and sponsor collaborations

  • The Human Parts of Mouse Models

    The Human Parts of Mouse Models

    Julia Schueler, Head of in vivo Operations, Oncotest, a Charles River company ||October 11, 2016
    The PDX model system has come back into focus